- 1. World Health Organization. Communicable disease surveillance and response. Disease outbreaks. Japanese encephalitis. Available from: www.who.int/disease-outbreak-news/disease/A83.0htm (accessed May 2004).
- 2. Hanna JN, Ritchie SA, Phillips DA, et al. An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust 1996; 165: 256-260. <MJA full text>
- 3. McCormack JG, Allworth AM. Emerging viral infections in Australia. Med J Aust 2002; 177: 45-49. <MJA full text>
- 4. Watt G, Jongsakul K. Acute undifferentiated fever caused by infection with Japanese encephalitis virus. Am J Trop Med Hyg 2003; 68: 704-706.
- 5. Rubin G, Baird J. New recommendation on Japanese encephalitis vaccination for travellers to Papua New Guinea [letter]. Med J Aust 2004; 181: 283.
- 6. Hanson JP, Taylor CT, Richards AR, et al. Japanese encephalitis acquired near Port Moresby: implications for residents and travellers to Papua New Guinea [letter]. Med J Aust 2004; 181: 282.
- 7. National Health and Medical Research Council. The Australian immunisation handbook. 8th ed. Canberra: NHMRC, 2003.
- 8. Ruff TA, Eisen D, Fuller A. Adverse reactions to Japanese encephalitis vaccine. Lancet 1991; 338: 881-882.
- 9. Aventis Pasteur. JE-VAX product information. Sydney: Aventis Pasteur, 1998.
- 10. Monath TP, Guirakhoo F, Nichols R, et al. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J Infect Dis 2003; 88: 1213-1230.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.